A 70-year-old woman was admitted to our hospital because of anemia with headache and nausea. As a result of anemia workup, she was diagnosed with ascending colon cancer with a para-aortic lymph node metastasis. Ileocecal resection and excision of an enlarged para-aortic lymph node were performed. Histopathological diagnosis of the resected specimen was poorly differentiated adenocarcinoma (solid type) with some mucinous carcinoma, and the metastatic lymph nodes showed differentiation into mucinous carcinoma. Immunohistologically, CD8
+T cell infiltration was observed in the cancer tissue, but mucinous carcinoma in the metastatic lymph nodes showed sparse CD8
+T cell infiltration. During chemotherapy for liver metastases after surgery, lymph node metastases appeared near the hepatic hilum. The histology of lymph node metastases was diagnosed as mucinous carcinoma based on CT findings, and pembrolizumab was administered due to microsatellite instability-high.Twenty-two months after the start of treatment with pembrolizumab, the metastatic lymph nodes were judged to be in partial response and have maintained the reduction. The disappearance of liver metastases was confirmed 25 months after the start of pembrolizumab treatment. In our case, the time to partial response in the metastatic lymph nodes was longer than the reported median time to objective response to pembrolizumab. It is possible that the differentiation into mucinous carcinoma at the metastatic site caused the suppression of the infiltration of CD8-positive T cells into cancer cell clusters. The difference in time to response between mucinous and non-mucinous carcinoma in patients treated with immune checkpoint inhibitor is a matter for further study.
抄録全体を表示